Home › Funds › Kingsview Wealth Management, LLC › JNJ

Kingsview Wealth Management, LLC position in JNJ

JOHNSON & JOHNSON · Health Care

Kingsview Wealth Management, LLC reported holding 95,588 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$25.3M, representing 0.33% of its reported portfolio and ranking #47 among its reported holdings. Kingsview Wealth Management, LLC has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)95.59K sh
Reported value held$25.31M
Portfolio Weight0.33%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Kingsview Wealth Management, LLC's JNJ position evolved

Kingsview Wealth Management, LLC first disclosed a stake in JNJ in Q3 2023 at 104,401 shares (US$16.3M). The position peaked in Q3 2026 at 95,588 shares, worth US$25.3M. Across 13 filings, Kingsview Wealth Management, LLC increased the stake 7 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 95,588 shares valued at US$25.3M — an increase of 1,445 shares quarter over quarter.. Notable position changes include a 31% increase in Q4 2023 (shares rose 1% over the following quarter), a 47% trim in Q1 2025 (shares fell 6% over the following quarter), a 26% increase in Q2 2025 (shares rose 22% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 104.40K $16.26M New
Q4 2023 136.38K $21.38M Add
Q1 2024 137.94K $21.82M Add
Q2 2024 146.95K $21.48M Add
Q3 2024 152.26K $24.67M Add
Q4 2024 142.37K $20.59M Reduce
Q1 2025 75.98K $12.60M Reduce
Q2 2025 95.89K $14.65M Add
Q3 2025 119.36K $22.13M Add
Q4 2025 106.85K $22.11M Reduce
Q1 2026 98.95K $24.19M Reduce
Q2 2026 94.14K $23.91M Reduce
Q3 2026 95.59K $25.31M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Kingsview Wealth Management, LLC held JNJ?

Kingsview Wealth Management, LLC has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Kingsview Wealth Management, LLC's current position in JNJ?

As of Q3 2026, Kingsview Wealth Management, LLC holds 95.59K shares of JNJ (JOHNSON & JOHNSON), valued at $25.31M, representing 0.33% of its reported portfolio and ranking #47.

Has Kingsview Wealth Management, LLC been buying or selling JNJ?

In the latest 13F filing (Q3 2026), Kingsview Wealth Management, LLC increased its position in JNJ. The position peaked in Q3 2026 at 95.59K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.